Total Funding
58
59
Total FundingPost-IPO Debt raised
Growth Score 58 in past quarter
10 pts
Heat Score 59 in past quarter
13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
29109
Accuray is a biomedical company that provides medical practices with tumor treatment solutions.
- Seth Blacksburg: VP, Chief Medical Officer of the Americas
- Paul Miele: Senior Vice President and Chief Commercial OfficerPast Role: Johnson & Johnson, Business Unit Leader-Monarch
About the Company
Accuray Inc. The Group's principal activities are developing & manufacturing of Intelligent Robotic Radiosurgery Systems. Its major brands include CyberKnife System, RoboCouch Patient Positioning System, Xsight Lung Tracking System, the Xchange robotic collimator changer, the 4D Treatment Optimization and Planning System, Xsight Spine
Tracking System, Synchrony Respiratory Tracking System, MultiPlan Treatment Planning System, InView remote review system, AXUM treatment couch and In-Room CT System. The group operates in the United States, Europe, Asia & Japan.
